An evaluation of serum soluble CD30 levels and serum CE26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

N.M. Keane, Patricia Price, Silvia Lee, Shelley Stone, Martyn French

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)
Original languageEnglish
Pages (from-to)111-116
JournalClinical and Experimental Immunology
Issue numberN/A
Publication statusPublished - 2001

Cite this